Will Rigetti Computing Stock Hit $20 by the End of 2025?

Rigetti Computing (RGTI), a quantum computing startup currently trading around $11, offers full-stack quantum solutions including its Novera QPU priced at $900,000, and employs a superconducting approach to tackle quantum accuracy challenges. Despite its technological advancements, the company reported Q1 revenue of just $1.5 million, with sales growth constrained by reliance on government grants. The article suggests that while RGTI previously hit $20, its future stock performance and potential return to that level are highly speculative, contingent on securing significant commercial orders rather than current market fundamentals.

Analysis

Rigetti Computing (RGTI) presents a classic high-risk, high-reward profile typical of a pre-commercial deep-tech company. The firm has developed a tangible product, the 9-qubit Novera QPU, which is available for purchase at a starting price of $900,000 and features a 99.4% 2-qubit gate fidelity. This demonstrates technological progress and a clear path to market. However, this technical achievement is starkly contrasted by its financial performance, with Q1 revenue totaling a mere $1.5 million. Management attributes this low figure to the lumpy and currently constrained nature of sales, which are heavily reliant on government grants. The stock's previous high of $20 per share appears to have been driven by market hype rather than fundamental performance. Consequently, any potential return to that level is positioned as highly speculative and contingent on securing a significant, transformative commercial order, an event which is not guaranteed. The current market valuation, therefore, reflects a bet on future quantum computing adoption and Rigetti's ability to capture a major contract, rather than its existing revenue stream.

Key Decisions for Investors

• Treat Rigetti Computing as a speculative, event-driven holding, as its valuation is primarily influenced by industry hype and the potential for a large contract win, not by its current financial results.
• Investors should closely monitor company announcements for any significant commercial or government orders for the Novera QPU, as this is identified as the key catalyst that could justify a substantial re-rating of the stock.
• Given the minimal Q1 revenue of $1.5 million and reliance on unpredictable grant-based sales, exercise caution due to the stock's inherent volatility and its sensitivity to broad quantum computing headlines rather than consistent financial performance.